腺病毒载体生产的寨卡病毒样颗粒在小鼠中诱导长效中和抗体应答
本研究制备了寨卡病毒样颗粒(VLP)疫苗候选物并评估其在小鼠中的免疫原性。单剂未佐剂VLP或灭活寨卡病毒应答持续超6个月但体外不中和病毒;与铝佐剂、AddaVax或Pam2Cys联用时铝佐剂单剂最有效,可产生中和抗体并增加抗原特异性记忆B细胞,中和抗体持续至6个月。
要点
- 单剂未佐剂寨卡VLP或灭活病毒应答持续超6个月但不体外中和病毒。
- 铝佐剂单剂联用VLP产生中和抗体并增加抗原特异性记忆B细胞。
- 铝佐剂组中和抗体持续至6个月,作者提示单剂VLP可用于暴发场景。
核心结论
- 单剂寨卡VLP与铝佐剂联用可诱导中和抗体并增加抗原特异性记忆B细胞,中和抗体持续至6个月。
- 作者提示单剂寨卡VLP可能是适用于暴发场景的单剂疫苗候选物。
研究设计与样本
- 本研究制备寨卡病毒样颗粒(VLP)疫苗候选物并在小鼠中评估其免疫原性。
- 电镜下寨卡VLP形态与寨卡病毒相似,并可被抗黄病毒中和抗体识别。
主要发现
- 单剂未佐剂寨卡VLP或灭活寨卡病毒产生的免疫应答持续超过6个月,但未中和体外细胞感染。
- 寨卡VLP与氢氧化铝(Alhydrogel®;铝佐剂)、AddaVax或Pam2Cys联用时,铝佐剂在单剂方案中最有效。
- 铝佐剂组不仅产生中和病毒抗体,还产生更多抗原特异性记忆B细胞。
- 铝佐剂组中和抗体持续至6个月。
临床怎么用
- 作者认为单剂寨卡VLP可能是适用于暴发场景的单剂疫苗候选物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Countermeasures against Zika virus (ZIKV) epidemics are urgently needed. In this study we generated a ZIKV virus-like particle (VLP) based vaccine candidate and assessed the immunogenicity of these particles in mice. The ZIKV-VLPs were morphologically similar to ZIKV by electron microscopy and were recognized by anti-Flavivirus neutralising antibodies. We observed that a single dose of unadjuvanted ZIKV-VLPs, or inactivated ZIKV, generated an immune response that lasted over 6 months, but did not neutralize ZIKV infection of cells in vitro. However, when we co-administered the ZIKV VLPs with either Aluminium hydroxide (Alhydrogel®; Alum), AddaVax or Pam2Cys we observed that Alum was the most effective in a single dose regime, since it not only produced antibodies that neutralized the virus, but also generated a greater number of antigen-specific memory B cells. We additionally observed that the generation of the neutralising antibodies persisted for up to 6 months. Our results suggest that a single dose ZIKV VLPs could be a suitable single dose vaccine candidate for use in outbreak settings.
引用
- Carrera J, Aktepe TE, Earnest L, et al. Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice. Vaccine. 2023. PMID: 37391311. doi:10.1016/j.vaccine.2023.06.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。